California-based Arrowhead Pharmaceuticals, which has about 100 employees in Madison, signed a deal totaling $673 million with Amgen, one of the world’s largest biotechnology companies, to bring two drugs to market for the treatment of cardiovascular disease.
Arrowhead Pharma scores $673M drug deal
Get Our Email Newsletter
The companies, people and issues shaping business in Madison and the Capital Region.
